Linda Greub

Linda Greub, CFA, MBA, currently serves as a Board Member at Clarified Precision Medicine and as Managing Partner at Avestria Ventures, focusing on early-stage women's health and life science ventures. Additional board roles include positions at Mae and Raydiant Oximetry, Inc., as well as observerships at AmplifiDx. Previously, Linda Greub held the role of CEO at Muir Partners and was a partner at LMN Ventures, LLC, where seed capital was provided to early-stage companies in various sectors. Experience in corporate development includes leadership roles at RainDance Technologies and Singulex, along with strategic positions at Novartis. Educational credentials comprise an MBA from Harvard Business School, a BA from Yale University, and various programs at prestigious institutions like UCLA Anderson School of Management and Stanford Graduate School of Business.